Literature DB >> 31562746

Sex Differences in Escalated Methamphetamine Self-Administration and Altered Gene Expression Associated With Incubation of Methamphetamine Seeking.

Atul P Daiwile1, Subramaniam Jayanthi1, Bruce Ladenheim1, Michael T McCoy1, Christie Brannock1, Jennifer Schroeder1, Jean Lud Cadet1.   

Abstract

BACKGROUND: Methamphetamine (METH) use disorder is prevalent worldwide. There are reports of sex differences in quantities of drug used and relapses to drug use among individuals with METH use disorder. However, the molecular neurobiology of these potential sex differences remains unknown.
METHODS: We trained rats to self-administer METH (0. 1 mg/kg/infusion, i.v.) on an fixed-ratio-1 schedule for 20 days using two 3-hour daily METH sessions separated by 30-minute breaks. At the end of self-administration training, rats underwent tests of cue-induced METH seeking on withdrawal days 3 and 30. Twenty-four hours later, nucleus accumbens was dissected and then used to measure neuropeptide mRNA levels.
RESULTS: Behavioral results show that male rats increased the number of METH infusions earlier during self-administration training and took more METH than females. Both male and female rats could be further divided into 2 phenotypes labeled high and low takers based on the degree of escalation that they exhibited during the course of the METH self-administration experiment. Both males and females exhibited incubation of METH seeking after 30 days of forced withdrawal. Females had higher basal mRNA levels of dynorphin and hypocretin/orexin receptors than males, whereas males expressed higher vasopressin mRNA levels than females under saline and METH conditions. Unexpectedly, only males showed increased expression of nucleus accumbens dynorphin after METH self-administration. Moreover, there were significant correlations between nucleus accumbens Hcrtr1, Hcrtr2, Crhr2, and Avpr1b mRNA levels and cue-induced METH seeking only in female rats.
CONCLUSION: Our results identify some behavioral and molecular differences between male and female rats that had self-administered METH. Sexual dimorphism in responses to METH exposure should be considered when developing potential therapeutic agents against METH use disorder. Published by Oxford University Press on behalf of CINP 2019. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  craving; hypocretin; methamphetamine; self-administration; sexual dimorphism

Mesh:

Substances:

Year:  2019        PMID: 31562746      PMCID: PMC6902093          DOI: 10.1093/ijnp/pyz050

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  80 in total

1.  Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats.

Authors:  Carmela M Reichel; Clifford H Chan; Shannon M Ghee; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2012-05-17       Impact factor: 4.530

2.  Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat.

Authors:  H W Berendse; Y Galis-de Graaf; H J Groenewegen
Journal:  J Comp Neurol       Date:  1992-02-15       Impact factor: 3.215

3.  Treatment outcomes among women and men methamphetamine abusers in California.

Authors:  Yih-Ing Hser; Elizabeth Evans; Yu-Chuang Huang
Journal:  J Subst Abuse Treat       Date:  2005-01

4.  Sex differences in the ontogeny of CRF receptors during adolescent development in the dorsal raphe nucleus and ventral tegmental area.

Authors:  Jodi L Lukkes; Kevin J Norman; Shirisha Meda; Susan L Andersen
Journal:  Synapse       Date:  2016-01-12       Impact factor: 2.562

5.  Differential involvement of the core and shell subregions of the nucleus accumbens in conditioned cue-induced reinstatement of cocaine seeking in rats.

Authors:  Rita A Fuchs; K Allison Evans; Macon C Parker; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2004-05-11       Impact factor: 4.530

Review 6.  Representing sex in the brain, one module at a time.

Authors:  Cindy F Yang; Nirao M Shah
Journal:  Neuron       Date:  2014-04-16       Impact factor: 17.173

7.  Seasonal and diurnal changes of prostatic androgen receptor and circulating testosterone in young mature rats.

Authors:  H Moeller; B Goecke; F Herter
Journal:  Res Exp Med (Berl)       Date:  1988

Review 8.  Stress, sex, and addiction: potential roles of corticotropin-releasing factor, oxytocin, and arginine-vasopressin.

Authors:  Verónica Bisagno; Jean Lud Cadet
Journal:  Behav Pharmacol       Date:  2014-09       Impact factor: 2.293

Review 9.  Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction.

Authors:  Elena H Chartoff; Maria Mavrikaki
Journal:  Front Neurosci       Date:  2015-12-16       Impact factor: 4.677

10.  Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats.

Authors:  Jana Ruda-Kucerova; Petra Amchova; Zuzana Babinska; Ladislav Dusek; Vincenzo Micale; Alexandra Sulcova
Journal:  Front Psychiatry       Date:  2015-07-06       Impact factor: 4.157

View more
  16 in total

Review 1.  AMPed-up adolescents: The role of age in the abuse of amphetamines and its consequences on cognition and prefrontal cortex development.

Authors:  Sara R Westbrook; Lauren K Carrica; Asia Banks; Joshua M Gulley
Journal:  Pharmacol Biochem Behav       Date:  2020-08-20       Impact factor: 3.533

Review 2.  Neural mechanisms underlying incubation of methamphetamine craving: A mini-review.

Authors:  Rachel D Altshuler; Hongyu Lin; Xuan Li
Journal:  Pharmacol Biochem Behav       Date:  2020-10-23       Impact factor: 3.533

3.  Sex-Dependent Alterations in the mRNA Expression of Enzymes Involved in Dopamine Synthesis and Breakdown After Methamphetamine Self-Administration.

Authors:  Aaron E Miller; Atul P Daiwile; Jean Lud Cadet
Journal:  Neurotox Res       Date:  2022-07-14       Impact factor: 3.978

4.  Challenges and new opportunities for detecting endogenous opioid peptides in reward.

Authors:  Sineadh M Conway; Marwa O Mikati; Ream Al-Hasani
Journal:  Addict Neurosci       Date:  2022-04-03

5.  Sex- and Brain Region-specific Changes in Gene Expression in Male and Female Rats as Consequences of Methamphetamine Self-administration and Abstinence.

Authors:  Atul P Daiwile; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Neuroscience       Date:  2020-11-24       Impact factor: 3.590

6.  Chemogenetic Inhibition of Dopamine D1-expressing Neurons in the Dorsal Striatum does not alter Methamphetamine Intake in either Male or Female Long Evans Rats.

Authors:  Martin O Job; Michael R Chojnacki; Atul P Daiwile; Jean L Cadet
Journal:  Neurosci Lett       Date:  2020-05-01       Impact factor: 3.046

7.  Voluntary oral methamphetamine increases memory deficits and contextual sensitization during abstinence associated with decreased PKMζ and increased κOR in the hippocampus of female mice.

Authors:  Jorge A Avila; Nicoletta Memos; Abdurrahman Aslan; Tytus Andrejewski; Victoria N Luine; Peter A Serrano
Journal:  J Psychopharmacol       Date:  2021-09-29       Impact factor: 4.562

8.  Age-specific treatment effects of orexin/hypocretin-receptor antagonism on methamphetamine-seeking behavior.

Authors:  Natalie E Zlebnik; Nathan A Holtz; Victoria C Lepak; Amy T Saykao; Yanan Zhang; Marilyn E Carroll
Journal:  Drug Alcohol Depend       Date:  2021-04-27       Impact factor: 4.852

Review 9.  Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts.

Authors:  Atul P Daiwile; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Neurosci Biobehav Rev       Date:  2022-04-20       Impact factor: 9.052

10.  Genetic basis of variation in cocaine and methamphetamine consumption in outbred populations of Drosophila melanogaster.

Authors:  Brandon M Baker; Mary Anna Carbone; Wen Huang; Robert R H Anholt; Trudy F C Mackay
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.